Status:
UNKNOWN
New Needle for Two-Needle Hemodialysis
Lead Sponsor:
Biomedical Enterprises Inc
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Our preliminary studies have demonstrated that an innovative new design of the hemodialysis venous needle (the needle that returns the cleaned blood from the hemodialysis filter to the patient) with t...
Eligibility Criteria
Inclusion
- (1) end stage renal disease receiving hemodialysis in an ambulatory outpatient dialysis facility (2) male or female, (3) ages 18-80, (4) arterio-venous graft or AV fistula as vascular access,
Exclusion
- patients with fever, infection, inflammation or malignancy will be excluded
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2012
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01416896
Start Date
August 1 2011
End Date
September 1 2012
Last Update
August 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DaVita K Street Dialysis Center
Washington D.C., District of Columbia, United States, 20037